SUMMARY Routine screening of 404 742 sera by the automated micro-haemagglutination assay (AMHA-TP) and the Venereal Disease Research Laboratory (VDRL) test showed that 9848 specimens gave a reactive result to one of the three assays. Reactive results were confirmed by the fluorescent treponemal antibody absorption (FTA-ABS) test. The possibility of false-positive results varied from 0 04-0 3807o of all specimens or from 1 7-15* 7% of reactive sera. The VDRL test failed to detect reactivity in 56 54%o of sera from patients who had previously been infected with Treponema pallidum.
Introduction
Recent research into the serology of syphilis has concentrated on the identification of specific IgM and IgG antibodies against Treponema pallidum. The basic fluorescent treponemal antibody absorption (FTA-ABS) test however allows a margin of error'-5 which may be 6.8-10.7O7o,6 707o,7 or 37-2%0. 8 The sources of error may be non-specific group antibodies, the use of an inefficient sorbent, changes on the cell surface due to lyophilising of T pallidum, and to other factors.4 [9] [10] [11] [12] The occurrence of Tpallidum-specific antibodies of the IgM class seems to indicate early or active syphilitic infection whereas their disappearance after antibiotic treatment may prove a cure.'0 11 [13] [14] [15] [16] The methods used in these investigations are so far not precise enough for definite conclusions. 17 18 An improvement in methods is taking place in several research centres and promises a better approach in a few years.
The results of the T pallidum haemagglutination assay (TPHA) have been assessed by many workers in the last few years. 19 Of the 1377 sera showing reactive results to the AMHA-TP but non-reactive results to the FTA-ABS test and the VDRL test, a few may have occurred in patients at the beginning of the infection (before the third week) but, as far as could be traced, they were mainly found in patients who had contracted syphilis many years previously, were adequately treated, and were probably cured. Some sera came from old people who denied having had syphilis.
No history was obtainable from most of the donors. Further investigations to try to elucidate the reasons for an isolated reactive result to the AMHA-TP were undertaken but these results could have been non-specific (false-positive results) in several cases.
The results of the 4226 specimens which were reactive to the AMHA-TP and to the FTA-ABS test but not to the VDRL test indicate that the donors had syphilis, but the non-reactivity of the VDRL test suggests that the infection had occurred many years previously, had been treated successfully, or had disappeared spontaneously.
Since 3248 sera were reactive to the AMHA-TP, to the FTA-ABS, and to the VDRL tests, there can be no doubt the donors all had syphilis. Ninety-five specimens were reactive to the AMHA-TP and to the VDRL test but non-reactive to the FTA-ABS test, and 73 specimens were non-reactive to the AMHA-TP test but reactive to the FTA-ABS and VDRL 13 tests. These latter two groups comprise results which showed either false-reactivity or false non-reactivity in one of the two tests using treponemal antigens. The results for the 829 sera which were non-reactive to the AMHA-TP and the FTA-ABS test but reactive to the VDRL test can be considered biological falsepositive reactions.
The possibility of obtaining false results by the above method of screening may vary from 1 7 to 15-7% of the reactive samples and from 0 04 to 0 38% of all sera examined. The first figure constitutes an absolute minimum, the last an improbable maximum. The rate of specific reactivity of 1*84% (minimum) seems to be high but this is due to the selection of patients for serum antibody tests in most of the hospitals and dispensaries.
NON-REACTIVE RESULTS IN SELECTED GROUP
Results were obtained from 53 patients who were reactive to the AMHA-TP as well as to the FTA-ABS tests but non-reactive to the VDRL test. These patients were asked to attend for clinical examination. Of these, 10 had a history of a previous infection and had been adequately treated. Of the 43 who did not know that they had once had syphilis, 37 had no symptoms, four had mesaortitis with aortic diameters ranging from 40 to 50 mm on their radiographs (only one had attended the hospital because of cardiac complaints, one attended because of a leg ulcer, one had hepatic cirrhosis, and one had a keratoacanthoma), and two had changes of active neurosyphilis in the cerebrospinal fluid (one had tabes dorsalis and the other, clinically asymptomatic meningovascular syphilis with focal signs on electroencephalographs). Both these latter patients attended the department of urology, the first because he had difficulties of micturition (early tabetic paralysis of the bladder) and the other because of vague urological complaints. Late syphilis was discovered in all six patients by routine serum antibody tests.
These investigations could be performed on only 53 (1h25%) of 4226 patients and concern exclusively patients of the City Hospital, Lainz. These observations were therefore of a highly selected group and are not at all representative, although the results emphasise the importance of routine serological testing with the AMHA-TP instead of the VDRL test.
COMPARATIVE EVALUATION OF TESTS
In a comparative evaluation of the three tests (Table   II) Table  who were infected at one time with Tpallidum. The III. The sera of two patients were non-reactive but significance of detecting specific antibodies in the the CSF was reactive to the AMHA-TP test. Both sera of these patients has been emphasised by the patients had clinical features of tabes dorsalis, one serological results of the 53 selected patients already with markedly increased CSF protein (O 83 g/l) and mentioned.
a normal cell count (1/ml), the other with slightly 
